Superiority of a combined treatment of alfacalcidol and alendronate compared to the monotherapies in postmenopausal osteoporosis

被引：0

|

作者：

不详

机构：

来源：

CALCIFIED TISSUE INTERNATIONAL | 2006年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：S151 / S151

页数：1

相关论文

共 50 条

[1] Superiority of a combined treatment of alfacalcidol and alendronate compared to the monotherapies in postmenopausal osteoporosis
Ones, K.
Schacht, E.
[J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S20 - S20
[2] Superiority of a combined treatment of alfacalcidol and alendronate compared to the respective monotherapies in established osteoporosis
Ringe, J. D.
Farahmand, P.
Schacht, E.
[J]. OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S238 - S238
[3] Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
Ringe, J. D.
Farahmand, P.
Schacht, E.
Rozehnal, A.
[J]. RHEUMATOLOGY INTERNATIONAL, 2007, 27 (05) : 425 - 434
[4] Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial)
J. D. Ringe
P. Farahmand
E. Schacht
A. Rozehnal
[J]. Rheumatology International, 2007, 27 : 425 - 434
[5] COMBINED ALFACALCIDOL AND ALENDRONATE THERAPY IS SUPERIOR TO THE RESPECTIVE MONOTHERAPIES IN ESTABLISHED POSTMENOPAUSAL OR MALE OSTEOPOROSIS
Ringe, J. D.
Farahmand, P.
[J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S397 - S397
[6] Combined treatment with alendronate plus, alfacalcidol in established postmenopausal or male osteoporosis: A prospective, randomised controlled trial.
Ringe, J. D.
Faber, H.
Fahramand, P.
Dorst, A.
Schacht, E.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S308 - S309
[7] Antifracture efficacy of combined treatment with alendronate and alfacalcidol for osteoporosis in early-phase treatment
Miyakoshi, N.
Kasukawa, Y.
Kodama, H.
Noguchi, H.
Sasaki, H.
Kamo, K.
Shimada, Y.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S341 - S341
[8] Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis
Heijckmann, AC
Juttmann, JR
Wolffenbuttel, BHR
[J]. NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (08): : 315 - 319
[9] Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis
R. Nuti
G. Bianchi
M.L. Brandi
R. Caudarella
E. D’Erasmo
C. Fiore
G.C. Isaia
G. Luisetto
M. Muratore
P. Oriente
S. Ortolani
[J]. Rheumatology International, 2006, 26 : 445 - 453
[10] Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis
Nuti, R
Bianchi, G
Brandi, ML
Caudarella, R
D'Erasmo, E
Fiore, C
Isaia, GC
Luisetto, G
Muratore, M
Oriente, P
Ortolani, S
[J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (05) : 445 - 453

← 1 2 3 4 5 →